Peter Buzzacott Selected Research

Decompression Sickness (Bends)

12/2020	Effect of antiplatelet and/or anticoagulation medication on the risk of tympanic barotrauma in hyperbaric oxygen treatment patients, and development of a predictive model.
1/2017	Endothelia-Targeting Protection by Escin in Decompression Sickness Rats.
1/2016	Effect of simulated air dive and decompression sickness on the plasma proteome of rats.
12/2015	Antioxidants, endothelial dysfunction, and DCS: in vitro and in vivo study.
7/2015	Reactive Oxygen Species, Mitochondria, and Endothelial Cell Death during In Vitro Simulated Dives.
5/2015	Mechanism of action of antiplatelet drugs on decompression sickness in rats: a protective effect of anti-GPIIbIIIa therapy.
1/2015	Theoretical tissue compartment inert gas pressures during a deep dive with and without deep decompression stops: a case analysis.
11/2014	Different effect of l-NAME treatment on susceptibility to decompression sickness in male and female rats.
9/2014	Effect of splenectomy on platelet activation and decompression sickness outcome in a rat model of decompression.
1/2014	A new measure of decompression sickness in the rat.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter Buzzacott Research Topics

Disease

10	Decompression Sickness (Bends) 12/2020 - 01/2014
2	Overweight 01/2018 - 11/2013
2	Inflammation (Inflammations) 01/2017 - 05/2015
2	Pulmonary Edema 01/2017 - 12/2016
2	Hyperoxia 07/2015 - 11/2013
1	T-Cell Lymphoma (Lymphoma, T Cell) 03/2022
1	Barotrauma 12/2020
1	Air Embolism (Gas Embolism) 12/2020
1	Tinnitus 12/2020
1	Hearing Loss (Hearing Impairment) 12/2020
1	Pain (Aches) 12/2020
1	Hypertension (High Blood Pressure) 01/2018
1	Contact Dermatitis (Eczema, Contact) 04/2017
1	Hypersensitivity (Allergy) 04/2017
1	Chronic Disease (Chronic Diseases) 11/2014
1	Dehydration (Water Stress) 11/2014
1	Wounds and Injuries (Trauma) 11/2014

Drug/Important Bio-Agent (IBA)

3	Oxygen (Dioxygen)IBA 12/2020 - 11/2013
1	Procarbazine (Matulane)FDA Link 03/2022
1	Prednisolone (Predate)FDA LinkGeneric 03/2022
1	Vincristine (Oncovin)FDA LinkGeneric 03/2022
1	Lomustine (CCNU)FDA Link 03/2022
1	CholesterolIBA 01/2018
1	sulisobenzone (Uval)IBA 04/2017
1	propylene (propene)IBA 04/2017
1	ethyleneIBA 04/2017
1	4-O-carboxymethylascochlorinIBA 04/2017
1	Immunoglobulin E (IgE)IBA 04/2017
1	LatexIBA 04/2017
1	Rubber (Elastica)IBA 04/2017
1	E-SelectinIBA 01/2017
1	EscinIBA 01/2017
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 12/2016
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 12/2016
1	ProteomeIBA 01/2016
1	AntioxidantsIBA 12/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2015
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 05/2015
1	Abciximab (ReoPro)FDA Link 05/2015
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 11/2014
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2014
1	MetalsIBA 01/2014
1	SugarsIBA 11/2013

Therapy/Procedure

6	Decompression 01/2017 - 01/2014
2	Therapeutics 12/2020 - 05/2015
1	Drug Therapy (Chemotherapy) 03/2022
1	Splenectomy 09/2014